Schonfeld Strategic Advisors LLC - PHASEBIO PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 58 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of PHASEBIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$34,000
-84.5%
25,500
-51.6%
0.00%
-100.0%
Q3 2019$220,000
-81.5%
52,700
-41.7%
0.01%
-85.7%
Q2 2019$1,187,000
+97.8%
90,400
+43.5%
0.04%
+100.0%
Q1 2019$600,000–63,000–0.02%–
 Download
Other shareholders

There were no reported owners of PHASEBIO PHARMACEUTICALS INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of PHASEBIO PHARMACEUTICALS INC shareholders